United Therapeutics
Martine Rothblatt is Chairman & CEO of United Therapeutics, a
biotechnology company she started to save the life of one of her daughters.
The company offers FDA approved medicines for pulmonary hypertension
and neuroblastoma and is working on manufacturing an unlimited supply of transplantable organs.
Dr. Rothblatt previously created and led Sirius XM as its Chairman & CEO
and launched other satellite systems for navigation and international
television broadcasting. In the field of aviation her Sirius XM satellite
system enhances safety with real-time digital weather information to pilots
in flight nationwide. She also designed the world’s first electric helicopter
and piloted it to a Guinness world record for speed, altitude and flight
duration.
In the legal arena, Dr. Rothblatt led efforts of the transgender community
to establish their own health law standards, and of the International Bar
Association to protect autonomy rights in genetic information via an
international treaty. She also published dozens of scholarly articles and
papers on the law of outer space, resulting in her election to the
International Institute of Space Law, and represented the radio astronomy
community’s scientific research interests before the Federal
Communications Commission.
She has Bachelor’s (Communications Studies, Summa Cum Laude), JD
(Order of the Coif) and MBA degrees from UCLA, which in 2018 awarded
her its highest recognition, the UCLA Medal, as well as a Ph.D. in Medical
Ethics from the Royal London School of Medicine & Dentistry. Her
patented inventions cover aspects of satellite communication, medicinal
biochemistry and cognitive software.
Dr. Rothblatt’s recent books are on xenotransplantation (Your Life or Mine),
gender identity (Transgender to Transhuman) and cyberethics (Virtually
Human).